Follow-The-Filings

Security · featured owners

ANTX An2 Therapeutics Inc.

Health Care COM Equity among managers we track

ANTX (An2 Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$64.73M -$51.32M -$35.17M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $110.51M $86.26M $59.94M
Total non-current assets * $28.24M $5.82M $2.01M
Total assets $138.74M $92.09M $61.95M
Total current liabilities $14.04M — $8.72M
Total non-current liabilities * $0.00 — $170,000
Total equity $124.7M $81.85M $53.06M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$53.29M -$49.26M -$29.83M
Cash from investing -$43.28M $54.59M $28.31M
Cash from financing $84.99M $0.372M $0.113M
Net change in cash -$11.57M $5.7M -$1.41M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders